Navigation Links
China Biologic Products to Present at the Rodman & Renshaw Annual China Investment Conference
Date:3/3/2010

TAI'AN, China, March 3 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the Company's management team will present at the Rodman & Renshaw Annual China Investment Conference March 7 to 9, 2010 in Beijing, China.

The date, time and location of China Biologic's presentation at the Rodman & Renshaw Annual China Investment Conference are as follows:

    Date:      Monday, March 8, 2010
    Time:      10:15 a.m. to 10:40 a.m.
    Presenter: Mr. Chaoming Zhao, Chief Executive Officer
               Mr. Ming Yin, VP of Finance and Investor Relations
    Venue:     The Regent Hotel - Ball Room III
               No. 99 Jinbao Street, Dongcheng District
               Beijing 100005, China

During the conference, management will be available for one-on-one meetings with institutional investors. Interested parties please contact Lily Khaykina at LK@rodm.com or (212) 430-1714. Participation in the R&R Conference is by invitation only.

About China Biologic Products, Inc.

China Biologic Products, Inc. (the "Company"), through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd, and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently the largest non-state-owned plasma-based biopharmaceutical company in China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies, and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China.

    For more information, please contact:

    Company Contact:
     Mr. Y. Tristan Kuo
     Chief Financial Officer
     China Biologic Products, Inc.
     Tel:   +86-538-6202206
     Email: IR@chinabiologic.com
     Web:   http://www.chinabiologic.com

     Investor Relations Contact:
     Ms. Lei Huang, Account Manager
     CCG Investor Relations
     Tel:   +1-646-833-3417
     Email: lei.huang@ccgir.com
     Web:   http://www.ccgirasia.com

     Mr. Crocker Coulson, President
     Tel:   +1-646-213-1915
     Email: crocker.coulson@ccgir.com

SOURCE China Biologic Products, Inc.

Back to top

RELATED LINKS
http://www.chinabiologic.com
http://www.ccgirasia.com

'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2009 Financial Results
2. China Nepstar Chain Drugstore Announces Annual Dividend
3. Chinas leading electronic systems design event to highlight next-generation medical, automotive and green power technologies
4. QRxPharma Limited and China Aoxing Pharmaceutical Company Announce Strategic Alliance for Development of MoxDuo(R)IV
5. OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
6. Simcere Receives SFDA Approval to Manufacture and Sell Zanamivir in China
7. Candela Receives Registration Approval to Market Its Best-in-Class GentleMax and Alex TriVantage Lasers in China
8. Gorbec Pharmaceutical Services, Inc. Announces the Launch of Its GMP Analytical Laboratory in China
9. Chinas Basic Medical Insurance to Cover Sinobiopharmas Flagship Product
10. China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters
11. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical Center ... in Nashville , Tennesse have been ... Sphincter Stimulation for GERD (LESS GERD) trial. The EndoStim ... long-term reflux control by restoring normal function to the ... million people in the United States ...
(Date:4/19/2017)... , April 19, 2017 ... stimulate an immune response in pets such as ... products are of various types such as Attenuated ... Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated ... as virus or bacteria, which have been weakend ...
Breaking Medicine Technology:
(Date:4/27/2017)... DC (PRWEB) , ... April 27, 2017 , ... ... Behavioral Economics Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a groundbreaking ... recognition (IRR) field. Offering practical takeaways to apply immediately to IRR programs, the ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... Dan Gasby the 2017 Public Leadership in Neurology Award (PLINA). The couple joins ... athlete Tedy Bruschi, Vice President Walter Mondale, actor Michael J. Fox and former ...
(Date:4/27/2017)... City (PRWEB) , ... April 27, 2017 , ... Goodcents ... will open in the Lincoln, Neb. area this year. , The first new ... summer. The second location will open at 84th and Northern Lights Drive this fall. ...
(Date:4/27/2017)... Rosa, CA (PRWEB) , ... April 27, 2017 , ... ... Canales, MD , have been asked to present at the upcoming Aesthetic Meeting. Held ... from April 27-May 2. Drs. Furnas and Canales will lend their expertise to the ...
(Date:4/26/2017)... ... April 26, 2017 , ... Journal of Oral Implantology ... have severe consequences to overall dental health, including complications with speech, eating, and overcompensation ... dental implants to replace lost teeth. As the number of tooth replacements increase, it ...
Breaking Medicine News(10 mins):